stockrow
Saturday 7 November 2026
Export CMND’s income statement to Excel — free account
Clearmind Medicine Inc.
CMND Healthcare Biotechnology
- EPS
- +99.4%
- Free cash flow
- −77.9%
Quarter to July 2026, against a year earlier
5.40
0.45
−7.69%
Follow CMND
Alert me
| Older periods | Oct '25 | Jan '26 | Apr '26 | Jul '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(179.38%) | (119.72%) | (114.61%) | (106.98%) | |
| (57.83%) | (74.91%) | (80.22%) | (71.81%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(364.82%) | (81.82%) | (69.73%) | (58.72%) | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(2,959.06) | (383.03) | (165.08) | (35.74) | |
Free Cash Flow |
(4.73) | (5.55) | (6.22) | (7.07) | |
| Other line items | |||||
Cash ROIC |
(55.45%) | (29.88%) | (24.77%) | (23.10%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.02 | 0.01 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
— | (261.91) | (318.71) | — | |
Operating CF/Net income |
1.23 | 0.84 | 0.79 | 0.94 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(2,959.06) | (383.03) | (165.08) | (35.74) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 2 Nov 2026